<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang C</submitter><funding>Scientific and Technological Research Project of Xinjiang Production and Construction Corps</funding><funding>Training Program of the Autonomous Region</funding><funding>National Natural Science Foundation of China</funding><pagination>22-36</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12716619</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>75(1)</volume><pubmed_abstract>miRNAs are key regulators of metabolic homeostasis, yet their role in obesity-associated dysfunction remains incompletely understood. Here, we identify miR-432 as a driver of systemic metabolic dysregulation. Serum miRNA profiling revealed a positive correlation between miR-432 expression and obesity/type 2 diabetes mellitus. Functionally, adipose-specific miR-432 exacerbated high-fat diet-induced obesity and insulin resistance. Similarly, hepatic-specific miR-432 aggravated hepatic steatosis and systemic glucose dysregulation, while skeletal muscle-specific miR-432 disrupted glucose homeostasis without affecting body composition. Mechanistically, miR-432 disrupted insulin sensitivity by inhibiting the PIK3R3/AKT pathway and perturbed lipid homeostasis by suppressing the PIK3R3/PPAR-α axis. Notably, obesity-induced miR-432 upregulation was predominantly localized in adipocytes and driven by the CDK5/PPAR-γ axis. Furthermore, adipocyte-derived exosomal miR-432 was identified as a mediator of systemic metabolic dysfunction, facilitating intertissue cross talk in obesity. Collectively, our data demonstrate that miR-432 exacerbates obesity-induced dysregulation of glucose and lipid metabolism.&lt;h4>Article highlights&lt;/h4>miR-432 overexpression in adipose tissue, liver, and skeletal muscle exacerbates high-fat diet-induced disruption of metabolic homeostasis. miR-432 impairs glucose homeostasis by suppressing the PIK3R3/AKT pathway and disrupts lipid homeostasis via inhibition of the PIK3R3/PPAR-α axis or directly suppressing PPAR-α. Obesity-induced elevation of miR-432 is predominantly localized in adipocytes and driven by the CDK5/PPAR-γ axis. Adipocyte-derived exosomal miR-432 mediates systemic metabolic dysfunction, establishing an intertissue regulatory network.</pubmed_abstract><journal>Diabetes</journal><pubmed_title>miR-432 Exacerbates Obesity-Induced Dysregulation of Glucose and Lipid Homeostasis.</pubmed_title><pmcid>PMC12716619</pmcid><funding_grant_id>82260162</funding_grant_id><funding_grant_id>81960152</funding_grant_id><funding_grant_id>2022AB022</funding_grant_id><funding_grant_id>2023ZD037</funding_grant_id><funding_grant_id>2023AB057</funding_grant_id><funding_grant_id>2021AB028</funding_grant_id><funding_grant_id>82160156</funding_grant_id><funding_grant_id>2023TSYCCX0116</funding_grant_id><funding_grant_id>2022ZD001</funding_grant_id><funding_grant_id>2023TSYCQNTJ0032</funding_grant_id><pubmed_authors>Wang CY</pubmed_authors><pubmed_authors>Zhang J</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Sun C</pubmed_authors><pubmed_authors>Xie J</pubmed_authors><pubmed_authors>Chu X</pubmed_authors><pubmed_authors>Zhang M</pubmed_authors><pubmed_authors>Liang M</pubmed_authors><pubmed_authors>Hou Y</pubmed_authors><pubmed_authors>Wang J</pubmed_authors></additional><is_claimable>false</is_claimable><name>miR-432 Exacerbates Obesity-Induced Dysregulation of Glucose and Lipid Homeostasis.</name><description>miRNAs are key regulators of metabolic homeostasis, yet their role in obesity-associated dysfunction remains incompletely understood. Here, we identify miR-432 as a driver of systemic metabolic dysregulation. Serum miRNA profiling revealed a positive correlation between miR-432 expression and obesity/type 2 diabetes mellitus. Functionally, adipose-specific miR-432 exacerbated high-fat diet-induced obesity and insulin resistance. Similarly, hepatic-specific miR-432 aggravated hepatic steatosis and systemic glucose dysregulation, while skeletal muscle-specific miR-432 disrupted glucose homeostasis without affecting body composition. Mechanistically, miR-432 disrupted insulin sensitivity by inhibiting the PIK3R3/AKT pathway and perturbed lipid homeostasis by suppressing the PIK3R3/PPAR-α axis. Notably, obesity-induced miR-432 upregulation was predominantly localized in adipocytes and driven by the CDK5/PPAR-γ axis. Furthermore, adipocyte-derived exosomal miR-432 was identified as a mediator of systemic metabolic dysfunction, facilitating intertissue cross talk in obesity. Collectively, our data demonstrate that miR-432 exacerbates obesity-induced dysregulation of glucose and lipid metabolism.&lt;h4>Article highlights&lt;/h4>miR-432 overexpression in adipose tissue, liver, and skeletal muscle exacerbates high-fat diet-induced disruption of metabolic homeostasis. miR-432 impairs glucose homeostasis by suppressing the PIK3R3/AKT pathway and disrupts lipid homeostasis via inhibition of the PIK3R3/PPAR-α axis or directly suppressing PPAR-α. Obesity-induced elevation of miR-432 is predominantly localized in adipocytes and driven by the CDK5/PPAR-γ axis. Adipocyte-derived exosomal miR-432 mediates systemic metabolic dysfunction, establishing an intertissue regulatory network.</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-06-08T05:29:53.499Z</modification><creation>2026-06-08T03:08:27.15Z</creation></dates><accession>S-EPMC12716619</accession><cross_references><pubmed>41218910</pubmed><doi>10.2337/db25-0295</doi></cross_references></HashMap>